A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

Citations Over TimeTop 1% of 2020 papers

Abstract

Our study provides a validated SCD risk prediction model with >70% prediction accuracy and incorporates risk factors that are unique to pediatric hypertrophic cardiomyopathy. An individualized risk prediction model has the potential to improve the application of clinical practice guidelines and shared decision making for implantable cardioverter defibrillator insertion. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT0403679.

Related Papers

• → Hypertrophic Cardiomyopathy and Other Causes of Sudden Cardiac Death in Young Competitive Athletes, with Considerations for Preparticipation Screening and Criteria for Disqualification(2007)101 cited
• → Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy(2020)23 cited
• → Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy(2016)4 cited
• → Sudden Death in Patients with Hypertrophic Cardiomyopathy(1980)14 cited
• → Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD(2013)